These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
89 related articles for article (PubMed ID: 2972193)
1. Hairy cell leukemia and anti-leukocyte common antigen. Martin JM; Boras VF; Houwen B; Francovich N Am J Clin Pathol; 1988 Oct; 90(4):412-20. PubMed ID: 2972193 [TBL] [Abstract][Full Text] [Related]
2. Detection of minimal residual disease by immunostaining of bone marrow biopsies after 2-chlorodeoxyadenosine for hairy cell leukemia. Hakimian D; Tallman MS; Kiley C; Peterson L Blood; 1993 Sep; 82(6):1798-802. PubMed ID: 7691237 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of Leu-M5 (CD11c) in hairy cell leukemia by the alkaline phosphatase anti-alkaline phosphatase technique. Vardiman JW; Gilewski TA; Ratain MJ; Bitter MA; Bradlow BA; Golomb HM Am J Clin Pathol; 1988 Sep; 90(3):250-6. PubMed ID: 2458031 [TBL] [Abstract][Full Text] [Related]
4. Selection of a panel of monoclonal antibodies for monitoring residual disease in peripheral blood and bone marrow of interferon-treated hairy cell leukaemia patients. Falini B; Pileri SA; Flenghi L; Liberati M; Stein H; Gerli R; Minelli O; Martelli MF; Lauria F; Poggi S Br J Haematol; 1990 Dec; 76(4):460-8. PubMed ID: 1702309 [TBL] [Abstract][Full Text] [Related]
5. A multilobular variant of hairy cell leukemia with morphologic similarities to T-cell lymphoma. Hanson CA; Ward PC; Schnitzer B Am J Surg Pathol; 1989 Aug; 13(8):671-9. PubMed ID: 2665535 [TBL] [Abstract][Full Text] [Related]
6. Assessment of complete remission after 2-chlorodeoxyadenosine for hairy cell leukemia: utility of marrow immunostaining and measurement of splenic index. Tallman MS; Hakimian D; Dyrda S; Kiley C; Nemcek A; Peterson L Leuk Lymphoma; 1994; 14 Suppl 1():133-8. PubMed ID: 7529609 [TBL] [Abstract][Full Text] [Related]
7. The differential diagnosis of hairy cell leukemia with a panel of monoclonal antibodies. Falini B; Schwarting R; Erber W; Posnett DN; Martelli MF; Grignani F; Zuccaccia M; Gatter KC; Cernetti C; Stein H Am J Clin Pathol; 1985 Mar; 83(3):289-300. PubMed ID: 3156489 [TBL] [Abstract][Full Text] [Related]
8. Hairy cell leukemia and anti-leukocyte common antigen. Swanson PE; Manivel JC; Strickler JG Am J Clin Pathol; 1989 May; 91(5):630-1. PubMed ID: 2524160 [No Abstract] [Full Text] [Related]
9. Immunomorphologic analysis of bone marrow biopsies after treatment with 2-chlorodeoxyadenosine for hairy cell leukemia. Ellison DJ; Sharpe RW; Robbins BA; Spinosa JC; Leopard JD; Saven A; Piro LD Blood; 1994 Dec; 84(12):4310-5. PubMed ID: 7994047 [TBL] [Abstract][Full Text] [Related]
10. [Clinicopathologic study of 15 splenectomy specimens of patients with hairy cell leukemia]. Li ZQ; Chen HS; Liu EB; Sun Q; Fang LH; Sun FJ; Zhang PH; Yang QY; Qiu LG Zhonghua Bing Li Xue Za Zhi; 2009 Nov; 38(11):769-73. PubMed ID: 20079018 [TBL] [Abstract][Full Text] [Related]
11. The diagnosis and differential diagnosis of hairy cell leukemia in bone marrow and spleen. Burke JS; Rappaport H Semin Oncol; 1984 Dec; 11(4):334-46. PubMed ID: 6505703 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hairy cell leukemia with alternating cycles of pentostatin and recombinant leukocyte A interferon: results of a phase II study. Martin A; Nerenstone S; Urba WJ; Longo DL; Lawrence JB; Clark JW; Hawkins MJ; Creekmore SP; Smith JW; Steis RG J Clin Oncol; 1990 Apr; 8(4):721-30. PubMed ID: 2313337 [TBL] [Abstract][Full Text] [Related]